Smooth muscle tumors of the uterus: possibilities of preoperative diagnosis using imaging techniques
Ivanova L.B., Chekalova M.A., Davydova I.Yu., Valiev R.K., Saryev M.N., Kryazheva V.S., Olimov B.P.
The significance of preserving the reproductive potential of the female population is currently high all over the world. Uterine fibroids and leiomyosarcoma have become diagnosed more often in young patients; moreover, uterine leiomyosarcoma is characterized by an extremely aggressive course and an unfavorable prognosis. Successful preoperative diagnosis is crucial for further treatment planning. There are improvements in reconstructive plastic organ-preserving operations, at the same time minimally invasive techniques are preferred: myomectomy is more often performed through laparoscopic techniques, robot-assisted surgery, and hysteroscopic methods. In most cases, the final diagnosis is made only after surgical treatment, so the lack of morphological verification can lead to an unfavorable course of the disease.
The objective of this study is to analyze various imaging techniques, including ultrasound, magnetic resonance imaging, positron emission tomography, which are described in the scientific medical literature and devoted to modern aspects of preoperative differential diagnosis of benign and malignant smooth muscle tumors of the uterus. There are currently no clear diagnostic criteria that can improve the accuracy of preoperative diagnosis of uterine smooth muscle tumors of uncertain or obvious malignant potential.
Conclusion: Although a comprehensive approach with the use of various imaging techniques does not completely solve the issues of early diagnosis of uterine sarcoma, it makes it possible to obtain important information at the preoperative stage necessary to determine the correct management tactics for this category of patients.
Authors’ contributions: Ivanova L.B., Davydova I.Yu., Chekalova M.A., Valiev R.K., Saryev M.N. – writing the text of the manuscript, review of publications on this issue, design development; Kryazheva V.S., Olimov B.P. – editing the text, searching for literature on the subject of the article.
Conflicts of interest: The authors declare no possible conflicts of interest.
Funding: The study was conducted without sponsorship.
For citation: Ivanova L.B., Chekalova M.A., Davydova I.Yu., Valiev R.K., Saryev M.N., Kryazheva V.S., Olimov B.P. Smooth muscle tumors of the uterus: possibilities of preoperative diagnosis using imaging techniques.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2024; (5): 13-22 (in Russian)
https://dx.doi.org/10.18565/aig.2024.46
Keywords
leiomyosarcoma
uterine fibroids
myomectomy
MRI of the pelvic organs
ultrasound
imaging techniques
References
- Министерство здравоохранения Российской Федерации. Клинические рекомендации. Рак тела и саркомы матки. 2021: 5-7. [Ministry of Health of the Russian Federation. Сlinical guidelines. Body cancer and uterine sarcomas. 2021: 5-7. (in Russian)].
- Hosh M., Antar S., Nazzal A., Warda M., Gibreel A., Refky B. Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database. Int. J. Gynecol. Cancer. 2016; 26(6): 1098-104. https://dx.doi.org/10.1097/IGC.0000000000000720.
- Fadare O., Roma A.A. Atlas of uterine pathology. Springer; 2019: 136-41.
- Министерство здравоохранения Российской Федерации. Клинические рекомендации. Миома матки. 2022. [Ministry of Health of the Russian Federation. Clinical guidelines. Uterine fibroids. 2022. (in Russian)].
- Wood L.N., Jamnagerwalla J., Markowitz M.A., Thum D.J., McCarty P., Medendorp A.R. et al. Public awareness of uterine power morcellation through US Food and Drug Administration communications: analysis of google trends search term patterns. JMIR Public Health Surveill. 2018; 4(2): e47. https://dx.doi.org/10.2196/publichealth.9913.
- Wright J.D., Chen L., Burke W.M., Hou J.Y., Tergas A.I., Ananth C.V. et al. Trends in use and outcomes of women undergoing hysterectomy with electric power morcellation. JAMA. 2016; 316(8): 877-8. https://dx.doi.org/10.1001/jama.2016.9432.
- Мнацаканян И.К., Чекалова М.А., Лазарева Н.И., Феденко А.А. Ультразвуковая диагностика метастазов лейомиосаркомы матки. Саркомы костей, мягких тканей и опухоли кожи. 2014; (3-4): 37-43. [Mnatsakanyan I.K., Chekalova M.A., Lasareva N.I., Fedenko A.A. Ultrasound diagnostics of utrerus leiomyosarcoma metastases. Bone and soft tissue sarcomas, tumors of the skin. 2014; (3-4): 37-43. (in Russian)].
- Sun S., Bonaffini P.A., Nougaret S., Fournier L., Dohan A., Chong J. et al. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging. Diagn. Interv. Imaging. 2019; 100(10): 619-34. https://dx.doi.org/10.1016/j.diii.2019.07.007.
- Ludovisi M., Moro F., Pasciuto T., Di Noi S., Giunchi S., Savelli L. et al. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma. Ultrasound Obstet. Gynecol. 2019; 54(5): 676-87. https://dx.doi.org/10.1002/uog.20270.
- De Bruyn C., Ceusters J., Vanden Brande K., Timmerman S., Froyman W., Timmerman D. et al. Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study. Ultrasound Obstet. Gynecol. 2024; 63(5): 683-90. https://dx.doi.org/10.1002/uog.27535.
- Чекалова М.А. Ультразвуковая диагностика в онкогинекологии. Гл. 4. В кн.: Каприн А.Д., Ашрафян Л.А., Стилиди И.С., ред. Онкогинекология. Национальное руководство. М.: ГЭОТАР-Медиа; 2019: 51-76. [Chekalova M.A. Ultrasound diagnostics in oncogynecology. Ch. 4. In: Kaprin A.D., Ashrafyan L.A., Stilidi I.S., eds. Oncogynecology. National guide. Moscow: GEOTAR-Media; 2019: 51-76. (in Russian)].
- Трофименко И.А., Берген Т.А., Исакова Н.Б., Бакланова Н.С., Красильников С.Э. Корреляция результатов эхографии, магнитно-резонансной томографии и морфологии при саркомоподобной лейомиоме матки. Онкохирургия. 2013; 5(4): 28-32. [Trofimenko I.A., Bergen T.A., Isakova N.B., Baklanova N.S., Krasil’nikov S.E. Correlation of echography, magnetic resonance imaging, and morphology in sarcoma-like uterine leiomyoma. Oncosurgery. 2013; 5(4): 28-32. (in Russian)].
- Najibi S., Gilani M.M., Zamani F., Akhavan S., Zamani N. Comparison of the diagnostic accuracy of contrast-enhanced/DWI MRI and ultrasonography in the differentiation between benign and malignant myometrial tumors. Ann. Med. Surg. (Lond). 2021; 70: 102813. https://dx.doi.org/10.1016/j.amsu.2021.
- Kim H., Rha S.E., Shin Y.R., Kim E.H., Park S.Y., Lee S.L. et al. Differentiating uterine sarcoma from atypical leiomyoma on preoperative magnetic resonance imaging using logistic regression classifier: added value of diffusion-weighted imaging-based quantitative parameters. Korean J. Radiol. 2024; 25(1):43-54. https://dx.doi.org/10.3348/kjr.2023.0760.
- Raffone A., Raimondo D., Neola D., Travaglino A., Giorgi M., Lazzeri L. et al. Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: a systematic review and meta-analysis. Int. J. Gynaecol. Obstet. 2024; 165(1): 22-33. https://dx.doi.org/10.1002/ijgo.15136.
- Bura V., Pintican R.M., David R.E., Addley H.C., Smith J., Jimenez-Linan M. et al. MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants. Br. J. Radiol. 2021; 94(1125): 20210283. https://dx.doi.org/10.1259/bjr.20210283.
- Abdel Wahab C., Jannot A.S., Bonaffini P.A., Bourillon C., Cornou C., Lefrère-Belda M.A. et al. Diagnostic algorithm to differentiate benign atypical leiomyomas from malignant uterine sarcomas with diffusion-weighted MRI. Radiology. 2020; 297(2): 361-71. https://dx.doi.org/10.1148/radiol.2020191658.
- Sato K., Yuasa N., Fujita M., Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am. J. Obstet. Gynecol. 2014; 210(4): 368.e1-368.e8. https://dx.doi.org/10.1016/j.ajog.2013.12.028.
- Tasaki A., Asatani M.O., Umezu H., Kashima K., Enomoto T., Yoshimura N. et al. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density. Abdom. Imaging. 2015; 40(6): 1742-52. https://dx.doi.org/10.1007/s00261-014-0324-5.
- Lin G., Yang L.Y., Huang Y.T., Ng K.K., Ng S.H., Ueng S.H. et al. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma. J. Magn. Reson. Imaging. 2016; 43(2): 333-42. https://dx.doi.org/10.1002/jmri.24998.
- Smith J., Zawaideh J.P., Sahin H., Freeman S., Bolton H., Addley H.C. Differentiating uterine sarcoma from leiomyoma: BET1T2ER Check! Br. J. Radiol. 2021; 94(1125): 20201332. https://dx.doi.org/10.1259/bjr.20201332.
- Lakhman Y., Veeraraghavan H., Chaim J., Feier D., Goldman D.A., Moskowitz C.S. et al. Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur. Radiol. 2017; 27(7): 2903-15. https://dx.doi.org/10.1007/s00330-016-4623-9.
- Nunes R.F., Queiroz M.A., Buchpiguel C.A., Carvalho F.M., Carvalho J.P. Aberrant hypermetabolism of benign uterine leiomyoma on 18F-FDG PET/CT. Clin. Nucl. Med. 2019; 44(6): e413-e414. https://dx.doi.org/10.1097/RLU.0000000000002580.
- Ho K.C., Dean Fang Y.H., Lin G., Ueng S.H., Wu T.I., Lai C.H. et al. Presurgical identification of uterine smooth muscle malignancies through the characteristic FDG uptake pattern on PET scans. Contrast Media Mol. Imaging. 2018; 2018: 7890241. https://dx.doi.org/10.1155/2018/7890241.
- Цхай В.Б., Пашов А.И., Рачковская В.В. Проблемы дифференциальной диагностики лейомиосаркомы у пациенток, планирующих оперативное лечение по поводу миомы матки. Акушерство и гинекология. 2024; 1: 42-9. [Tskhai V.B., Pashov A.I., Rachkovskaya V.V. The problem of differential diagnosis of leiomyosarcoma in patients planning surgical treatment for uterine fibroids. Obstetrics and Gynecology. 2024; (1): 42-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2023.207.
Received 04.03.2024
Accepted 02.05.2024
About the Authors
Larisa B. Ivanova, PhD, Head of the Laboratory of Gynecology of the Department of Pelvic Oncosurgery, A.S. Loginov Moscow Clinical Scientific Center, Moscow Department of Health, 111123, Russia, Moscow, Shosse Entusiastov, 86, +7(495)304-30-35, l.ivanova@mknc.ru, https://orcid.org/0000-0002-3307-5733Marina A. Chekalova, Dr. Med. Sci., Professor at the Department of Radiology and Ultrasound Diagnostics, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the FMBA of Russia, 115682, Moscow, Orekhovy Boulevard, 28, +7(903)1995096, ch2me@yandex.ru,
https://orcid.org/0000-0002-5565-2511
Irina Yu. Davydova, Dr. Med. Sci., Leading Researcher at the Department of Pelvic Organ Oncosurgery, A.S. Loginov Moscow Clinical Scientific Center, Moscow Department of Health, 111123, Russia, Moscow, Shosse Entusiastov, 86, +7(495)304-30-35, i.davydova@mknc.ru
Ramiz K. Valiev, PhD, Head of the Department of Pelvic Organ Oncosurgery, A.S. Loginov Moscow Clinical Scientific Center, Moscow Department of Health,
111123, Russia, Moscow, Shosse Entusiastov, 86, +7(495)304-30-35, r.valiev@mknc.ru
Mukhamed N. Saryev, oncologist at the Department of Pelvic Organ Oncosurgery, A.S. Loginov Moscow Clinical Scientific Center, Moscow Department of Health,
111123, Russia, Moscow, Shosse Entusiastov, 86, +7(495)304-30-35, m.saryyev@mknc.ru
Varvara S. Kryazheva, PhD, doctor of ultrasound diagnostics, Kommunarka Moscow Multifunctional Clinical Center, Center for Outpatient Oncological Care, Moscow Department of Health, 117303, Russia, Moscow, Azovskaya str., 22, +7(916)468-71-87, salvaje2005@yandex.ru, https://orcid.org/0000-0003-0934-7011
Behruz P. Olimov, PhD, radiologist at the Roentgenodiagnostic Department, A.S. Loginov Moscow Clinical Center, Moscow Department of Health, 111123, Russia, Moscow, Shosse Entusiastov, 86, +7(966)328-12-18, AlimovBP90@gmail.com, https://orcid.org/0000-0002-8467-6942
Similar Articles
